BLPH logo

Bellerophon Therapeutics (BLPH) EV/EBITDA

EV/EBITDA

N/A

Mon, 01 Jan 0001 00:00:00 GMT


Summary


Performance

BLPH EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

OtherBLPHvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

BLPH EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
6 m6 months---
1 y1 year---
5 y5 years---

BLPH EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month
3 m3-month0.390.34
6 m6-month0.390.34
1 y1-year0.390.31
3 y3-year0.56-7.51
5 y5-year0.56-7.96
alltimeall time0.56-7.96

Bellerophon Therapeutics EV/EBITDA History

DateValue
2024
0.38(+5.6%)
2023
0.36(-500.0%)
2022
-0.09(-69.0%)
2021
-0.29(-56.7%)
2020
-0.67(-30.2%)
DateValue
2019
-0.96(-12.7%)
2018
-1.10(-77.4%)
2017
-4.87(+4770.0%)
2016
-0.10(-85.3%)
2015
-0.68

FAQ

  • What is the all time high EV/EBITDA for Bellerophon Therapeutics?

What is the all time high EV/EBITDA for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high EV/EBITDA is 0.56